Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-31
1999-02-16
Green, Lora M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514256, 514262, 514263, A01N 4390
Patent
active
058721240
ABSTRACT:
The process of treating a disease of the central nervous system with an agent from one or more of the following three classes of agents: (1) nitric oxide scavengers, (2) peroxynitrite scavengers, and (3) agents that either interfere with the synthesis of iNOS in the cell or the enzymatic activity of iNOS in the cell.
REFERENCES:
patent: 5449688 (1995-09-01), Wahl et al.
patent: 5455279 (1995-10-01), Lipton
patent: 5464857 (1995-11-01), Maeda et al.
Cross AH, et al, (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93:2684-2690.
Dawson VL, et al, (1996) Nitric oxide neurotoxicity. J Chem.Neuroanat. 10:179-190.
Heales SJ, et al, (1994) Trolox protects mitochondrial complex IV from nitric oxide- mediated damage in astrocytes. Brain Res. 668:243-245.
Iadecola C, et al, (1995) Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am.J Physiol. 268:R286-R292.
Kooy NW, et al, (1994) Agonist-induced peroxynitrite production from endothelial cells. Arch.Biochem.Biophys. 310:352-359.
Maeda H, et al, (1994) Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J Leukoc.Biol. 56:588-592.
Takaaki Akaike et al., Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain, Journal of NeuroVirology (1995), vol. 32, 118-125.
Omar Bagasra et al., Activation of the inducible from of nitric oxide synthase in the brains of patients with multiple sclerosis, Proc. Natl. Acad. Sci. USA (Dec. 1995) 12041-12045.
D. Craig Hooper et al., Local nitric oxide production in viral and autoimmune diseases of the central nervous system, Proc. Natl. Acad. Sci. USA (Jun. 1995) 5312-5316.
Hilary Koprowski et al., In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases, Proc. Natl. Acad. Sci. USA (1993) 3024-3027.
Sergei V. Spitsin et al., Characterization and Functional Analysis of the Human Inducible Nitric Oxide Synthase Gene Promoter, Molecular Medicine (Mar. 1996) 226-235.
Takaaki Akaike et al., Antagonistic Action of Imidazolineoxly N-Oxides against Endothelium-Derived Relaxing Factor/.sup..cndot. NO through a Radical Reaction, Biochemistry (1993), vol. 32, 827-832.
Nuran Akgoren et al., Importance of nitric oxide for local increases of blood flow in rat cerebellar cortex during electrical stimulation, Proc. Natl. Acad. Sci. USA (1994), vol. 91, 5903-5907.
Joseph S. Beckman, Peroxynitrite versus Hydroxyl Radical: The Role of Nitric Oxide in Superoxide-Dependent Cerebral Injury, Annals New York Academy of Sciences (1994) 69-75.
Avraham Ben-Nun et al., The rapid isolation of clonable antigen-specific T Iymphocyte lines capable of mediating autoimmune encephalomyellitis, Eur. J. Imunol (1981), vol. 11, 195-199.
Anne H. Cross et al., Aminoguanidine, an Inhibitor of Inducible Nitric Oxide Synthase, Ameliorates Experimental Autoimmune Encephalomyelitis in SJL Mice, The American Society for Clinical Investigation, Inc. (1994), vol. 11, 2684-2690. in Biological Fluids, Analytical Biochemistry 126 (1982), vol. 126, 131-138.
Robert L. Knobler et al., Genetic Regulation of Susceptibility and Severity of Demyelination, Annals New York Academy of Sciences, vol. 540, 735-737.
Robert Korngold et al., Acute Experimental Allergic Encephalomyelitis in Radiation Bone Marrow Chimeras Between High and Low Susceptible Strains of Mice, Immunogenetics (1986), vol. 24, 309-315.
Robin F. Lin et al., Nitric Oxide Localized to Spinal Cords of Mice with Experimental Allergic Encephalomyelitis: An Electron Paramagnetic Resonance Study, J. Exp. Med. (1993), vol. 178, 643-648.
Harald H. H. W. Schmidt et al., NO at Work, Cell (1994), vol. 78, 919-925.
Solomon H. Snyder et al., Biological Roles of Nitric Oxide, Scientific American (May 1992) 68-77.
Klaus Tschaikowsky et al., Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609), Br. J. Pharmacol (1994), vol. 113, 664-668.
J. Zielasek et al., Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis, Journal of Neuroimmunology (1995), vol. 58, 81-88.
Hooper et al., Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis, National Academy of Sciences of the USA (Mar., 1997), vol. 94, pp. 2528-2533.
Akaike et al., Antagonistic Action of Imidazolineoxyl N-Oxides against Endothelium-Derived Relaxing Factor/.cndot.NO through a Radical Reaction, Biochemistry (1993), vol. 32, pp. 827-832.
Liu et al., Nitrite and Nitrosamine Synthesis by Hepatocytes Isolated from Normal Woodchucks (Marmota monax) and Woodchucks Chronically Infected with Woodchuck Hepatitis Virus, Cancer Research (Aug. 1992), vol. 52, pp. 4139-4143.
Mollace et al., HIV Coating gp 120 Glycoprotein-Dependent Prostaglandin E.sub.2 Releases by Human Cultured Atrocytoma Cells ia Regulated Nitric Oxide Formation, Biochemical and Biophysical Research (1994), vol. 203, pp. 87-93.
V. Mollace et al., HIV gp 120 Glycoprotein Stimulates the Inducible Isoform of NO Synthase in Human Cultured Astrocytoma Cells, Biochemical and Biophysical Research (Jul. 1993), vol. 194, pp. 439-445.
J. A. Lyon et al., Inhibition of Nitric Oxide Induction from Avian Macrophage Cell Lines by Influenza Virus, Avian Diseases (1993), vol. 37, pp. 868-873.
V. Dawson et al., Human immunodeficiency virus type 1 coat neurotoxicity mediated by nitric oxide in primary cortical cultures, National Academy of Science of the USA, (1993), vol. 90, pp. 3256-3259.
G Karupiah et al., Inhibition of Viral Replication by Interferon-y-Induces Nitric Oxide Synthase, Reports (1993), vol. 261, pp. 1445-1448.
Melkova et al., Interferon-y- Severely Inhibits DNA Synthesis of Vaccinia Virus in a Macrophage Cell Line, Virology (1994), vol. 198, pp. 731-735.
Y. Zheng et al., Severity of Neurological Signs and Degree of Inflammatory Lesions in the Brains of Rats with Borna Disease Correlate with the Induction of Nitric Oxide Synthase, Journal of Virology, (1993), pp. 5786-5791.
D. Pietraforte et al., gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages, Journal of Leukocyte Biology, (1994), vol. 55, pp. 175-182.
K. D. Croen, Evidence for an Antiviral Effect of Nitric Oxide, The American Society for Clinical Investigation, (1993), vol. 91, pp. 2246-2452.
E. Butz et al., Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis, Microbial Pathogenesis (1994), vol. 16, pp. 283-295.
Farber John L.
Hooper Douglas Craig
Koprowski Hilary
Green Lora M.
Thomas Jefferson University
LandOfFree
Treatment of diseases of the central nervous system using uric a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diseases of the central nervous system using uric a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diseases of the central nervous system using uric a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062702